A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients

PURPOSE: Amrubicin is one of the most active chemotherapeutic drugs for small cell lung cancer (SCLC). Previous studies reported its effectiveness and severe hematological toxicity. However, the efficacy of amrubicin monotherapy in elderly patients with SCLC has not been described. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Hisao, Sugiyama, Tomohide, Tamura, Tomohiro, Minemura, Hiroyuki, Kaira, Kyoichi, Kanazawa, Kenya, Yokouchi, Hiroshi, Kasai, Takashi, Kaburagi, Takayuki, Minato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573757/
https://www.ncbi.nlm.nih.gov/pubmed/28761968
http://dx.doi.org/10.1007/s00280-017-3403-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573757/
https://www.ncbi.nlm.nih.gov/pubmed/28761968
http://dx.doi.org/10.1007/s00280-017-3403-9

Ejemplares similares